Parliamentary questions
4 May 2010
H-0230/10
ORAL QUESTION for Question Time at the part-session in May 2010 pursuant to Rule 116 of the Rules of Procedure by Lena Ek to the Commission

 Subject: Actions by the Commission for EU measures to control endocrine-disrupting chemicals - companies and safer alternatives to BPA
 Answer 

Retailers and manufacturers of baby products all over the world are moving to replace the chemical bisphenol A (BPA), which is used to make polycarbonate plastic and is known for its hormone-disrupting properties. Its suspected impact is greatest on disorders associated with metabolism, fertility and neural development. Polycarbonate plastic is widely available in tins of food and canned drinks, and in a wide array of plastic products such as mobile phones, computers and medical equipment.

How does the Commission intend to encourage EU companies to be among the first movers in using and developing safer alternatives, while also ensuring the EU’s competitiveness?

Last updated: 5 May 2010Legal notice